You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

~ Buy the ADASUVE (loxapine) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR ADASUVE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for ADASUVE

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00444028 ↗	Staccato Loxapine Single Dose PK	Completed	Alexza Pharmaceuticals, Inc.	Phase 1	2005-09-01	The objective of this study was to assess the safety, tolerability and pharmacokinetics of a single inhaled dose of (administered in 1 or 2 puffs) Staccato Loxapine in healthy volunteers.
NCT00489476 ↗	Staccato Loxapine in Migraine (in Clinic)	Completed	Alexza Pharmaceuticals, Inc.	Phase 2	2007-06-01	The objective of this trial is to assess the efficacy and safety of Staccato Loxapine in patients with migraine headache with or without aura in a clinical setting.
NCT00543062 ↗	Staccato Prochlorperazine Thorough QT/QTc	Completed	Alexza Pharmaceuticals, Inc.	Phase 1	2007-10-01	To assess the safety of Staccato Prochlorperazine on cardiac repolarization (QTc interval duration) at 2 dose levels compared to placebo in healthy volunteers.
NCT00628589 ↗	Staccato Loxapine in Agitated Patients With Schizophrenia	Completed	Alexza Pharmaceuticals, Inc.	Phase 3	2008-02-01	Phase 3 safety and efficacy study of Staccato Loxapine in the treatment of acute agitation in schizophrenic patients
NCT00825500 ↗	Staccato Loxapine in Migraine (Out Patient)	Completed	Alexza Pharmaceuticals, Inc.	Phase 2	2009-01-01	Assess the safety and efficacy of Staccato Loxapine in patients with moderate to severe migraine headache with or without aura in an outpatient setting.
NCT00874237 ↗	Staccato Loxapine Thorough QT/QTc Study	Completed	Alexza Pharmaceuticals, Inc.	Phase 1	2009-04-01	The purpose of the present Phase 1 study was to assess the cardiac safety of Staccato Loxapine administered to healthy volunteers in a 3 period crossover study.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for ADASUVE

Condition Name

Chart
Table

Condition Name for ADASUVE
Intervention	Trials
Migraine	2
Agitation,Psychomotor	2
Schizophrenia	2
Healthy Volunteers	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for ADASUVE
Intervention	Trials
Psychomotor Agitation	4
Schizophrenia	3
Headache	2
Migraine Disorders	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for ADASUVE

Trials by Country

Map
Table

Trials by Country for ADASUVE
Location	Trials
United States	13
Netherlands	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for ADASUVE
Location	Trials
Indiana	4
Georgia	2
Missouri	1
Massachusetts	1
Arkansas	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for ADASUVE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for ADASUVE
Clinical Trial Phase	Trials
Phase 4	3
Phase 3	2
Phase 2	2
[disabled in preview]	5
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for ADASUVE
Clinical Trial Phase	Trials
Completed	11
Unknown status	1
Terminated	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ADASUVE

Sponsor Name

Chart
Table

Sponsor Name for ADASUVE
Sponsor	Trials
Alexza Pharmaceuticals, Inc.	9
Teva Branded Pharmaceutical Products R&D, Inc.	1
Teva Branded Pharmaceutical Products, R&D Inc.	1
[disabled in preview]	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for ADASUVE
Sponsor	Trials
Industry	12
Other	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.